Bibliograph

Drug safety, preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse

Type

Label

Drug safety, preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse

Language

eng

Bibliography note

Includes bibliographical references

resource.governmentPublication

federal national government publication

Illustrations

illustrationsmaps

Index

no index present

Literary Form

non fiction

Main title

Drug safety

Medium

electronic resource

Nature of contents

bibliographydictionaries

Oclc number

184738729

Responsibility statement

statement of Marcia Crosse

Series statement

Testimony, GAO-08-224 T

Sub title

preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

resource.variantTitle

Drug safety, preliminary findings suggest weaknesses in Food and Drug Administration's program for inspecting foreign drug manufacturersPreliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers

Contributor

Creator